Suppr超能文献

肌酐-胱抑素C比值对无尿腹膜透析患者死亡率和技术失败的预测价值

Predictive value of creatinine-cystatin C ratio for mortality and technique failure in anuric peritoneal dialysis patients.

作者信息

Zhang Zhihong, Zhou Tingting, Zhang Man, Cheng Shuiqin

机构信息

National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China.

出版信息

Ren Fail. 2025 Dec;47(1):2444389. doi: 10.1080/0886022X.2024.2444389. Epub 2025 Jan 2.

Abstract

OBJECTIVES

Both serum creatinine and cystatin C serve as dependable markers of renal function and have demonstrated a correlation with clinical outcomes in diverse conditions, particularly through the ratio of creatinine to cystatin C (Cr/CysC). Anuric patients undergoing peritoneal dialysis (PD) depend entirely on the clearance of peritoneal solutes. This research posits that the Cr/CysC ratio may predict all-cause mortality and technique failure in anuric PD patients.

METHODS

A cohort of 224 anuric PD patients was recruited from January 1, 2014, to December 31, 2019, with follow-up extending until December 31, 2023. The Cr/CysC ratio was computed by dividing the serum creatinine concentration by the cystatin C concentration obtained on the same day. We evaluated the relationship between the Cr/CysC ratio and patient survival, as well as technique failure, utilizing Cox regression and competing risk analyses.

RESULTS

The average age of the participants was 50.46 ± 12.63 years, with 99 individuals (44.2%) being male. Among all subjects, the Cr/CysC ratio was found to be 1.85 ± 0.56. After controlling for potential confounders, Cox proportional hazards models revealed that the Cr/CysC ratio was significantly linked to the risk of all-cause mortality and technique failure (HR = 0.330, 95% CI 0.124-0.881,  = 0.027; HR = 0.440, 95% CI 0.267-0.726,  = 0.002). Importantly, the significant associations observed in the Cox regression analysis persisted even after accounting for competing risks.

CONCLUSION

The Cr/CysC ratio at baseline was recognized as an independent predictor of all-cause mortality and technique failure in anuric PD patients.

摘要

目的

血清肌酐和胱抑素C均为可靠的肾功能标志物,并且已证实在多种情况下与临床结局相关,尤其是通过肌酐与胱抑素C的比值(Cr/CysC)。接受腹膜透析(PD)的无尿患者完全依赖腹膜溶质清除。本研究假定Cr/CysC比值可预测无尿PD患者的全因死亡率和技术失败。

方法

从2014年1月1日至2019年12月31日招募了224名无尿PD患者队列,随访至2023年12月31日。Cr/CysC比值通过将血清肌酐浓度除以同一天获得的胱抑素C浓度来计算。我们利用Cox回归和竞争风险分析评估了Cr/CysC比值与患者生存率以及技术失败之间的关系。

结果

参与者的平均年龄为50.46±12.63岁,其中99人(44.2%)为男性。在所有受试者中,Cr/CysC比值为1.85±0.56。在控制潜在混杂因素后,Cox比例风险模型显示Cr/CysC比值与全因死亡率和技术失败风险显著相关(HR = 0.330,95%CI 0.124 - 0.881,P = 0.027;HR = 0.440,95%CI 0.267 - 0.726,P = 0.002)。重要的是,即使在考虑竞争风险后,Cox回归分析中观察到的显著关联仍然存在。

结论

基线时的Cr/CysC比值被认为是无尿PD患者全因死亡率和技术失败的独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff8f/11702990/6f8b9c3785cd/IRNF_A_2444389_F0001_B.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验